TABLE 3.
Dosing Directions | Dosing Device | ||||
---|---|---|---|---|---|
Recommendation | Relevant sample | No./Total No. |
% of Relevant Sample |
No./Total No. |
% of Relevant Sample |
Standard abbreviations used for volumetric units (e.g., "mL" used instead of "ml") | Products using abbreviations | 59/65 | 91 | 49/68 | 72 |
Abbreviations for volumetric units on dosing device match the directions (e.g., if “mL” used in directions, “mL” used on device) | Products using abbreviations in directions and on dosing device | -- | -- | 52/65 | 80 |
Abbreviations for volumetric units defined (e.g., “mL=milliliter”)b | Products using abbreviations | 18/68 | 26 | 0/68 | 0 |
No extraneous numeric doses appear on the dosing device that do not correspond to amounts in the directions | Products with dosing devices | -- | -- | 19/68 | 28 |
Statement included that only enclosed dosing device should be used or mechanism used to secure dosing device to the bottlec | Products with dosing devices | 33/68 | 49 | 32/68 | 47 |
Not applicable denoted by (--)
Low Tier recommendations maintain conventional standards of abbreviation and capitalization. They improve clarity and consistency but are not directly linked to potential ≥3-fold dosing errors. Products were assessed for adherence to recommendations in "Guidance for Industry: Dosage Delivery Devices for Orally Ingested OTC Liquid Drug Products", US Food and Drug Administration (FDA), May 2011 and "Volumetric Measures for Dosing of Over-the-Counter Oral Liquid Drug Products for Children ≤ 12 years of Age", Consumer Healthcare Products Association (CHPA), November 2009.
FDA guidance recommends that abbreviations should be defined on the dosing device (e.g., mL = milliliter) or, if they are not, should be defined in the labeled dosing directions, outside packaging, bottle, and any accompanying written instructions.
FDA guidance recommends that manufacturers should try to ensure that the dosing devices are used only with the products with which they are included. Possible ways of accomplishing this are to include a related statement on the drug product's bottle and/or carton labeling and, if possible, on the dosing device or to devise a mechanism to secure the dosing device to the drug product.